Fintel reports that on October 3, 2024, Evercore ISI Group downgraded their outlook for Academy Sports and Outdoors (NasdaqGS ...

In a report released today, Michael Binetti from Evercore ISI maintained a Buy rating on Burlington Stores (BURL – Research Report), with ...

Evercore ISI analyst James West maintained a Buy rating on EVgo (EVGO – Research Report) today and set a price target of $7.00. The ...

He's not the only fan of Amazon on Wall Street. Of the 47 analysts surveyed by LSEG in October, 43 rate the stock as a "buy" ...

Fintel reports that on October 2, 2024, Evercore ISI Group initiated coverage of Moody's (NYSE:MCO) with a Outperform ...

The port strike that began Tuesday is expected to boost Union Pacific Corp. shares thanks to the railroad's extensive operations in the Western U.S., analysts say. The strike at East Coast and Gulf ...

Evercore ISI raised the firm’s price target on Bausch + Lomb to $19 from $17 and keeps an In Line rating on the shares. In ...

Stocks fell in Tokyo and Sydney after the S&P 500 slid 0.9%, with contracts pointing to further declines for the US benchmark ...

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But ...

On Friday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $462.88 which represents a decrease of $-0.27 or -0.06% from the prior close of $463.15. The stock opened ...

Shortly after winning full FDA approval for its rare kidney disease drug Filspari, San Diego’s Travere Therapeutics has run ...

As of the latest trading close, TPR, a Consumer Cyclical sector stock, is trading -3.67% below its 52-week high but remains 80.88% above its 52-week low. The Average True Range (ATR) (14 days) of 1.21 ...